Correlation Between China Development and OBI Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both China Development and OBI Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Development and OBI Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China Development Financial and OBI Pharma, you can compare the effects of market volatilities on China Development and OBI Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Development with a short position of OBI Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Development and OBI Pharma.

Diversification Opportunities for China Development and OBI Pharma

-0.8
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between China and OBI is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding China Development Financial and OBI Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OBI Pharma and China Development is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Development Financial are associated (or correlated) with OBI Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OBI Pharma has no effect on the direction of China Development i.e., China Development and OBI Pharma go up and down completely randomly.

Pair Corralation between China Development and OBI Pharma

Assuming the 90 days trading horizon China Development Financial is expected to generate 0.82 times more return on investment than OBI Pharma. However, China Development Financial is 1.21 times less risky than OBI Pharma. It trades about 0.13 of its potential returns per unit of risk. OBI Pharma is currently generating about -0.17 per unit of risk. If you would invest  1,670  in China Development Financial on September 2, 2024 and sell it today you would earn a total of  50.00  from holding China Development Financial or generate 2.99% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

China Development Financial  vs.  OBI Pharma

 Performance 
       Timeline  
China Development 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in China Development Financial are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, China Development is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
OBI Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OBI Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

China Development and OBI Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with China Development and OBI Pharma

The main advantage of trading using opposite China Development and OBI Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Development position performs unexpectedly, OBI Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OBI Pharma will offset losses from the drop in OBI Pharma's long position.
The idea behind China Development Financial and OBI Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
CEOs Directory
Screen CEOs from public companies around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum